AEs Attributed to Avelumab
ADVERSE EVENTS, EVENTS
The immune-related adverse events (irAEs) attributed to avelumab are described in Incidence of treatment-related adverse events attributed to avelumab.€ = there were no grade 5 events in any patient.
Incidence of serious adverse events (SAE).
